Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong, Benjamin Chun-Yu; Lam, Shiu Kum; Wong, Wai Man; Chen, Jian Shun; Zheng, Ting Ting; Feng, Rui E; Lai, Kam Chuen; Hu, Wayne Hsing Cheng; Yuen, Siu Tsan; Leung, Suet Yi; Fong, Daniel Yee Tak; Ho, Joanna; Ching, Chi Kong; Chen, Jun Shi.
; 291(2): 187-94, 2004 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-14722144
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Helicobacter pylori eradication for the prevention of gastric neoplasia.
Dynamics of <i>Helicobacter pylori</i> infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
Gastric Cancer: How Can We Reduce the Incidence of this Disease?
Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging.
The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries.
Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer.
Helicobacter pylori, gastritis nodular y lesiones premalignas de estómago: un estudio de casos y controles.
A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management.
Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.